review of literature on clinical pancreatology - The Pancreapedia

358. Koornstra JJ, Mourits MJ, Sijmons RH, Leliveld AM, Hollema H, Kleibeuker JH. Management <strong>of</strong>extracolonic tumours in patients with Lynch syndrome. Lancet Oncol 2009; 10: 400-8.359. Buchholz M, Gress TM. Molecular changes in pancreatic cancer. Expert Rev Anticancer Ther2009; 9: 1487-97.360. Ranganathan P, Harsha HC, Pandey A. Molecular alterations in exocrine neoplasms <strong>of</strong> thepancreas. Arch Pathol Lab Med 2009; 133: 405-12.361, Fujii K, Miyashita K, Yamada Y, Eguchi T, Taguchi K, Oda Y, Oda S, Yoshida MA, Tanaka M,Tsuneyoshi M. Simulation-based analyses reveal stable microsatellite sequences in human pancreaticcancer. Cancer Genet Cytogenet 2009; 189: 5-14.362. Kahlert C, Weber H, Mogler C, Bergmann F, Schirmacher P, Kenngott HG, Matterne U, MollbergN, Rahbari NN, Hinz U, Koch M, Aigner M, Weitz J. Increased expression <strong>of</strong> ALCAM/CD166 inpancreatic cancer is an independent prognostic marker for poor survival and early tumor relapse. Br JCancer 2009; 101: 457-64.363. Welsch T, Keleg S, Bergmann F, Bauer S, Hinz U, Schmidt J. Actinin-4 expression in primary andmetastasized pancreatic ductal adenocarcinoma. Pancreas 2009; 38: 986-76.364. Zhang C, Shao Y, Zhang W, Wu Q, Yang H, Zhong Q, Zhang J, Guan M, Yu B, Wan J. Highresolutionmelting analysis <strong>of</strong> ADAMTS9 methylation levels in gastric, colorectal, and pancreaticcancers. Ancer Genet Cytogenet 2010; 196: 38-44.365. Bedrood S, Jayasinghe S, Sieburth D, Chen M, Erbel S, Butler PC, Langen R, Ritzel RA. AnnexinA5 directly interacts with amyloidogenic proteins and reduces their toxicity. Biochemistry 2009; 48:10568-76.366. Ryschich E, Khamidjano A, Kerkadze V, Büchler MW, Zoller M, Schmidt J. Promotion <strong>of</strong> tumorcell migration by extracellular matrix proteins in human pancreatic cancer. Pancreas 2009; 38: 804-10.367. Lawniczak M, Gawin A, Białek A, Lubiński J, Starzyńska T. Is there any relationship betweenBRCA1 gene mutation and pancreatic cancer development? Pol Arch Med Wewn 2008; 118: 645-9.368. Yamato I, Sho M, Nomi T, Akahori T, Shimada K, Hotta K, Kanehiro H, Konishi N, Yagita H,Nakajima Y. Clinical importance <strong>of</strong> B7-H3 expression in human pancreatic cancer. Br J Cancer 2009;101: 1709-16.369. Seeley ES, Carrière C, Goetze T, Longnecker DS, Korc M. Pancreatic cancer and precursorpancreatic intraepithelial neoplasia lesions are devoid <strong>of</strong> primary cilia. Cancer Res 2009; 69: 422-30.370. Zhao D, Xu D, Zhang X, Wang L, Tan W, Guo Y, Yu D, Li H, Zhao P, Lin D. Interaction <strong>of</strong>cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role <strong>of</strong> nucleophosmin.Gastroenterology 2009; 136: 1659-68.371. Dewald GW, Smyrk TC, Thorland EC, McWilliams RR, Van Dyke DL, Keefe JG, Belongie KJ,Smoley SA, Knutson DL, Fink SR, Wiktor AE, Petersen GM. Fluorescence in situ hybridization tovisualize genetic abnormalities in interphase cells <strong>of</strong> acinar cell carcinoma, ductal adenocarcinoma,and islet cell carcinoma <strong>of</strong> the pancreas. Mayo Clin Proc 2009; 84: 801-10.372. Maréchal R, Demetter P, Nagy N, Berton A, Decaestecker C, Polus M, Closset J, Devière J,Salmon I, Van Laethem JL. High expression <strong>of</strong> CXCR4 may predict poor survival in resectedpancreatic adenocarcinoma. Br J Cancer 2009; 100: 1444-51.373. Scola L, Giacalone A, Marasà L, Mirabile M, Vaccarino L, Forte GI, Giannitrapani L, Caruso C,Montalto G, Lio D. Genetic determined downregulation <strong>of</strong> both type 1 and type 2 cytokine pathwaysmight be protective against pancreatic cancer. Ann N Y Acad Sci 2009; 1155: 284-8.